What Is Tesamorelin and Why Does the Research Community Use It?

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Its sequence mirrors the full 44-amino-acid structure of endogenous GHRH with a trans-3-hexenoic acid modification at the N-terminus, which improves stability against enzymatic degradation. That structural detail matters when evaluating a vendor, because any deviation in synthesis can produce a compound that behaves differently in a research context.

The only FDA-approved form of tesamorelin is Egrifta SV, a prescription drug indicated specifically for the reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. That approval belongs to the branded pharmaceutical product, not to any research-chemical version sold online. Vendors selling tesamorelin as a research compound are offering a non-approved substance, and buyers should understand that distinction clearly before proceeding.

Research interest in tesamorelin extends beyond the approved indication. A 2016 study published in JAMA Neurology (n=152) examined tesamorelin's effects on cognition in older adults, finding modest improvements in executive function in a subset of participants. Animal studies have explored its influence on IGF-1 levels and body composition. These are preclinical and small human studies, not grounds for therapeutic claims, and a vendor who cites them as proof of a product's health benefits is misrepresenting the science.

What Does a Legitimate Research-Compound COA Actually Look Like?

A certificate of analysis is the single most important document a vendor can provide, and most buyers don't know how to read one critically. A credible COA names a specific third-party laboratory, carries a dated batch number that matches what's on the product label, and reports purity as a percentage derived from HPLC (high-performance liquid chromatography). For a peptide like tesamorelin, purity at or above 98% by HPLC is the standard serious researchers expect. A COA that simply says '99% pure' with no methodology listed is a marketing document, not an analytical one.

Mass spectrometry confirmation is the second layer of verification. HPLC tells you how much of the sample is your target compound relative to impurities. Mass spec tells you whether the compound is actually tesamorelin at all, by confirming the molecular weight and fragmentation pattern. Tesamorelin has a molecular weight of approximately 5135 Da. A COA that includes an MS spectrum with that confirmed mass is meaningfully more trustworthy than one that reports HPLC purity alone.

Batch transparency means the COA on the vendor's website corresponds to the specific vial you receive. Some vendors post a single COA from a year ago and apply it to every product they ship. Ask whether the batch number on your shipment matches the COA posted online. Legitimate vendors update their COAs with each new production run and make older ones available for comparison. If a vendor cannot answer that question directly, treat it as a red flag.

Look also at what the COA tests for beyond purity. Residual solvents, heavy metals, and endotoxin levels matter for any compound used in cell culture or animal research. A COA that only reports HPLC purity is incomplete by the standards of serious research supply. This doesn't mean every vendor needs to run every test on every batch, but a vendor who offers no explanation of what they do and don't test for is leaving buyers to guess.

Red Flags That Should End the Search Immediately

Health claims are the most obvious disqualifier. Any vendor page that says tesamorelin 'treats' lipodystrophy, 'reverses' aging, 'burns fat', or 'boosts growth hormone for better results' is making unapproved drug claims about a non-approved substance. This isn't just a legal problem for the vendor. It signals that the company is willing to mislead buyers, which raises the question of what else on the site is inaccurate.

Human-use administration language written as personal guidance is a second hard stop. Phrases like 'inject X mg daily' or 'run for 12 weeks' have no place on a research-chemical vendor's product page. Published clinical trials describe what study participants received under controlled conditions. A vendor presenting that information as personal guidance is crossing a line that distinguishes a research supplier from an unlicensed pharmacy. The 2016 JAMA Neurology trial, for example, described the amounts administered to participants in a supervised research setting. That is a fact about a study, not a template for personal use.

No verifiable contact information, no physical address, and no clear return or refund policy are operational red flags. Research-compound vendors operate in a legally complex space, but legitimate ones still maintain traceable business identities. A vendor with only a contact form, no stated jurisdiction, and a no-questions-asked policy that evaporates after purchase is not a supplier worth trusting with a research budget.

Pressure tactics and scarcity language round out the warning list. 'Last 10 units', countdown timers, and 'exclusive member pricing' are conversion tricks borrowed from supplement marketing. A vendor whose product page reads like a late-night infomercial is optimizing for impulse purchases, not for the methodical procurement decisions that research use requires.

Shipping, Storage Claims, and What Vendors Owe You in Writing

Tesamorelin is a peptide, which means it degrades under heat, humidity, and UV exposure. A vendor's shipping and storage disclosures tell you whether they understand the product they're selling. Cold-pack shipping for warm-weather orders, clear guidance on storage temperature ranges based on published stability data, and honest statements about shelf life are all markers of a supplier who takes product integrity seriously.

Refund and replacement policies should be written down and findable before purchase, not buried in a terms-of-service page linked in a footer. Legitimate vendors specify what constitutes a valid claim, what documentation is needed (photos of damaged packaging, batch numbers), and what the resolution timeline looks like. Vague language like 'we stand behind our products' with no concrete process attached is not a policy.

Shipping legality is another area where vendor transparency matters. Tesamorelin is not a controlled substance under the U.S. Controlled Substances Act, but it occupies a regulatory gray area as a non-approved research compound. Some vendors ship internationally; others restrict to domestic addresses. A vendor who is clear about what they will and won't ship, and why, is demonstrating more operational honesty than one who simply promises discreet delivery with no further explanation.

Sourcing Criteria: What the Checklist Looks Like

Pulling together everything above, a vendor worth considering for tesamorelin research supply should clear a short but non-negotiable list. Third-party COAs with batch-specific HPLC purity at or above 98%, mass-spectrometry confirmation of molecular identity, and testing for residual solvents or endotoxins are the analytical baseline. Any vendor who cannot provide all three on request is not meeting the standard that serious research procurement requires.

On the business side, a verifiable physical or registered address, a written refund and replacement policy, and product pages free of health claims or human-use administration language are the minimum markers of a legitimate operation. These aren't high bars. They're the basics that separate a research-supply company from a gray-market storefront.

Pricing is worth a brief note. Tesamorelin is a longer, more complex peptide than something like BPC-157, and legitimate synthesis costs reflect that. Prices that seem dramatically lower than the market average are worth scrutinizing. Undercutting on price often means cutting corners on synthesis quality, third-party testing, or both. A COA from a named, verifiable laboratory costs money. Vendors who absorb that cost without passing it on to buyers are either operating at a loss or skipping the testing.

The research-use framing is not a legal technicality to be skimmed past. Tesamorelin sold as a research compound is not approved for human use, is not equivalent to Egrifta SV, and should not be purchased with personal administration in mind. Buyers who approach this market with that understanding, and who apply the criteria above, are in a much better position to find supply that meets the standards their research actually requires.